5AM, NEA Lead $50M Bet on Akouos, Crafting Gene Therapy for the Ear

Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $169 per year, you reward quality independent biotech reporting, and encourage more.